Press Releases

Media Inquiries - media@caredx.com

Date	Title and Summary	Additional Formats
Toggle Summary Mar 11, 2021	CareDx Names Ankur Dhingra as New Chief Financial Officer SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,	View HTML
Toggle Summary Feb 25, 2021	CareDx Expands into the Pre-Transplant Kidney Space through TX Connect TX Connect adds 19,000 patient referrals for kidney transplant and continues CareDx’s focus on the patient journey SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and	View HTML
Toggle Summary Feb 24, 2021	CareDx Reports Fourth Quarter and Full Year 2020 Results SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Feb 23, 2021	Spotlight on CareDx’s Symposium at the Upcoming Cutting Edge of Transplantation (CEoT) Meeting SOUTH SAN FRANCISCO, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,	View HTML
Toggle Summary Feb 12, 2021	CareDx to Report Fourth Quarter and Full Year 2020 Financial Results SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Feb 11, 2021	CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares SOUTH SAN FRANCISCO, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Feb 10, 2021	CareDx to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference SOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Feb 05, 2021	CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT CareDx and Atara Biotherapeutics’ AlloCell Partnership Highlighted in Poster Presentation at Upcoming TCT Meeting SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and	View HTML
Toggle Summary Jan 25, 2021	CareDx Announces Closing of Public Offering of Common Stock SOUTH SAN FRANCISCO, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Jan 20, 2021	CareDx Announces Pricing of Public Offering of Common Stock SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML